**Core Concept**
Von Hippel-Lindau (VHL) Syndrome is a hereditary disorder characterized by the development of multiple vascular tumors, including retinal hemangioblastomas and hemangioblastomas in the central nervous system. The syndrome is caused by mutations in the VHL gene, which encodes a tumor suppressor protein involved in the regulation of angiogenesis and cell growth.

**Why the Correct Answer is Right**
In VHL Syndrome, retinal hemangioblastomas are often associated with intracranial hemangioblastomas, particularly in the cerebellum. The cerebellum is a common site for the development of hemangioblastomas in VHL patients, and these tumors can cause neurological symptoms such as ataxia, tremors, and gait disturbances. The cerebellar hemangioblastomas are thought to arise from the abnormal activation of the VEGF (vascular endothelial growth factor) pathway, which leads to the formation of new blood vessels and tumor growth.

**Why Each Wrong Option is Incorrect**
* **Option A:** While the brainstem is a critical structure in the central nervous system, it is less commonly associated with hemangioblastomas in VHL Syndrome compared to the cerebellum.
* **Option B:** The spinal cord is a rare site for the development of hemangioblastomas in VHL patients, and it is not typically associated with retinal vascular tumors.
* **Option D:** The suprasellar region is not a common site for hemangioblastomas in VHL Syndrome, and it is not typically associated with retinal vascular tumors.

**Clinical Pearl / High-Yield Fact**
In VHL Syndrome, the presence of retinal hemangioblastomas should prompt a thorough evaluation of the central nervous system for other vascular tumors, particularly in the cerebellum.

**Correct Answer:** C.